Why the study?
Does therapeutic plasma exchange improve outcomes in pregnant women with familial hypertriglyceridemia-induced pancreatitis?
Does therapeutic plasma exchange improve outcomes in pregnant women with familial hypertriglyceridemia-induced pancreatitis?
Therapeutic plasma exchange is an effective treatment for gestational hypertriglyceridemia-induced pancreatitis, allowing for safe delivery.
May warrant consideration in refractory cases; single-case evidence leaves open need for prospective validation.
Familial severe hypertriglyceridemia (levels greater than 1000 mg/dL) is a known cause of acute pancreatitis. Pregnancy can dysregulate controlled lipid levels in women with familial hypertriglyceridemia and lead to acute pancreatitis and significant morbidity in both mother and fetus. We report a case of hypertriglyceridemia-induced pancreatitis during pregnancy that was successfully treated using therapeutic plasma exchange, resulting in delivery of a healthy preterm infant. Therapeutic plasma exchange is an effective approach to treat gestational hypertriglyceridemia-induced pancreatitis. Other treatment options include combined heparin and insulin infusion. Moreover, particular caution should be applied when interpreting the results of prothrombin time in the setting of severe hypertriglyceridemia as false elevation with testing methods could happen.
No takes yet. Share an insight, caveat, or question.
Safi et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: